4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-20-007683
Chief Legal Officer sold 2,948 shares at an average $102.36 ($301,763)
From the SEC's structured data for this filing
Trades in this filing
Lippoldt Darin · Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-05 | Sale : show line 1 in the form | −1,145 | $102.88 | $117,800 | 21,133 | D |
| 2020-02-05 | Sale : show line 2 in the form | −605 | $103.15 | $62,407 | 21,678 | D |
| 2020-02-06 | Sale : show line 3 in the form | −1,198 | $101.47 | $121,556 | 22,755 | D |
| Open-market sales · 2,948 sh · avg $102.36 · $301,763 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-02-06 | Grant or award : show line 4 in the form Stock Option | +49,844 | $102.90 | 2030-02-06 | 49,844 | 49,844 | D |
| 2020-02-06 | Grant or award : show line 5 in the form Restricted Stock Unit | +7,897 | 7,897 | 7,897 | D |
Loading xslF345X03/doc4.xml…